scholarly article | Q13442814 |
P2093 | author name string | Devanand Sarkar | |
Luni Emdad | |||
Paul B Fisher | |||
Praveen Bhoopathi | |||
Swadesh K Das | |||
Xue-Ning Shen | |||
Anjan K Pradhan | |||
Nathaniel Lee | |||
P2860 | cites work | AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX | Q24305389 |
Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139 | Q28139691 | ||
Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis | Q28140307 | ||
Interleukin-10 and related cytokines and receptors | Q28251518 | ||
A Novel Anticancer Agent, 8-Methoxypyrimido[4',5':4,5]thieno(2,3-b) Quinoline-4(3H)-One Induces Neuro 2a Neuroblastoma Cell Death through p53-Dependent, Caspase-Dependent and -Independent Apoptotic Pathways | Q28534098 | ||
Cytochrome c release from mitochondria proceeds by a two-step process | Q28571562 | ||
Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter | Q33762359 | ||
Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24 | Q33870560 | ||
Phosphorylation of histone H2A.X by DNA-dependent protein kinase is not affected by core histone acetylation, but it alters nucleosome stability and histone H1 binding | Q33885281 | ||
The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. | Q33937973 | ||
Role of AIF in caspase-dependent and caspase-independent cell death | Q33977411 | ||
Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice | Q34048220 | ||
H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy. | Q34089263 | ||
Retracted: SPARC Overexpression Inhibits Cell Proliferation in Neuroblastoma and Is Partly Mediated by Tumor Suppressor Protein PTEN and AKT | Q34261684 | ||
Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression | Q34369804 | ||
MST1 promotes apoptosis through phosphorylation of histone H2AX | Q34386080 | ||
Cell death independent of caspases: a review. | Q34415492 | ||
Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid | Q34438516 | ||
A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels | Q34701049 | ||
Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach | Q34946787 | ||
Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV). | Q35095082 | ||
Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes | Q35142325 | ||
mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity | Q35189796 | ||
Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine | Q35209685 | ||
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma | Q35755392 | ||
mda-7/IL-24: exploiting cancer's Achilles' heel | Q35976805 | ||
Overview of cell death signaling pathways | Q36051647 | ||
MDA-7/IL-24: multifunctional cancer killing cytokine | Q36248193 | ||
Is mda-7/IL-24 a "magic bullet" for cancer? | Q36313094 | ||
Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death | Q36325171 | ||
Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer | Q36387940 | ||
A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments | Q36740744 | ||
Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy? | Q36810258 | ||
Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin | Q37261069 | ||
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. | Q37411957 | ||
Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction. | Q37561261 | ||
p53 in survival, death and metabolic health: a lifeguard with a licence to kill | Q38540071 | ||
Cambogin Induces Caspase-Independent Apoptosis through the ROS/JNK Pathway and Epigenetic Regulation in Breast Cancer Cells. | Q38874622 | ||
Adenovirus arming human IL-24 inhibits neuroblastoma cell proliferation in vitro and xenograft tumor growth in vivo | Q39162230 | ||
AIF-mediated caspase-independent necroptosis requires ATM and DNA-PK-induced histone H2AX Ser139 phosphorylation. | Q39280123 | ||
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells | Q39740442 | ||
Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells | Q40393341 | ||
BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation. | Q40578148 | ||
Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. | Q40606858 | ||
Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants | Q40972934 | ||
Resistance to chemotherapy mediated by TrkB in neuroblastomas. | Q44220743 | ||
Apoptosis-inducing factor (AIF): caspase-independent after all. | Q47961272 | ||
Identification and characterization of AIFsh2, a mitochondrial apoptosis-inducing factor (AIF) isoform with NADH oxidase activity | Q48090258 | ||
Improved survival in neuroblastoma using multimodality therapy | Q70516406 | ||
Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression | Q77733241 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell death | Q2383867 |
neuroblastoma | Q938205 | ||
P304 | page(s) | 3572-3582 | |
P577 | publication date | 2016-04-13 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM. | |
P478 | volume | 76 |
Q47560447 | Cancer Terminator Viruses (CTV): A Better Solution for Viral-Based Therapy of Cancer. |
Q91755726 | Effects of melanoma differentiation associated gene-7 (MDA-7/IL-24) on apoptosis of liver cancer cells via regulating the expression of B-cell lymphoma-2 |
Q64374902 | MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF |
Q93135528 | Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking |
Q89519701 | Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model |
Q64072222 | Murine astrocytes produce IL-24 and are susceptible to the immunosuppressive effects of this cytokine |
Q50186335 | New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity |
Q89206404 | Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway |
Q92578211 | Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin |
Q54254089 | Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases. |
Q59806800 | The Interleukin-10 Family of Cytokines and Their Role in the CNS |
Q41190055 | miR-203a-3p.1 targets IL-24 to modulate hepatocellular carcinoma cell growth and metastasis |
Search more.